Cornerstone Investment Partners, LLC Entrada Therapeutics, Inc. Transaction History
Cornerstone Investment Partners, LLC
- $1.93 Billion
- Q1 2025
A detailed history of Cornerstone Investment Partners, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Cornerstone Investment Partners, LLC holds 10,943 shares of TRDA stock, worth $77,476. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,943
Previous 11,889
7.96%
Holding current value
$77,476
Previous $205,000
52.2%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding TRDA
# of Institutions
111Shares Held
28.7MCall Options Held
8.2KPut Options Held
2.3K-
Baker Bros. Advisors LP New York, NY4.87MShares$34.4 Million0.52% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$31.2 Million27.61% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$31 Million57.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.74MShares$19.4 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X02.12MShares$15 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $222M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...